BRPI0919857A2 - tratamentos para cancer com radiacao e imunocitocinas - Google Patents

tratamentos para cancer com radiacao e imunocitocinas

Info

Publication number
BRPI0919857A2
BRPI0919857A2 BRPI0919857A BRPI0919857A BRPI0919857A2 BR PI0919857 A2 BRPI0919857 A2 BR PI0919857A2 BR PI0919857 A BRPI0919857 A BR PI0919857A BR PI0919857 A BRPI0919857 A BR PI0919857A BR PI0919857 A2 BRPI0919857 A2 BR PI0919857A2
Authority
BR
Brazil
Prior art keywords
immunocytocin
radiation
cancer treatments
treatments
cancer
Prior art date
Application number
BRPI0919857A
Other languages
English (en)
Portuguese (pt)
Inventor
Karl Josef Kallen
Stephan G Klinz
Sylvia A Holden
Thomas Wickham
Ulrike Gnad-Vogt
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BRPI0919857A2 publication Critical patent/BRPI0919857A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0919857A 2008-10-21 2009-10-21 tratamentos para cancer com radiacao e imunocitocinas BRPI0919857A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10714608P 2008-10-21 2008-10-21
PCT/EP2009/007533 WO2010046097A1 (en) 2008-10-21 2009-10-21 Cancer treatments with radiation and immunocytokines

Publications (1)

Publication Number Publication Date
BRPI0919857A2 true BRPI0919857A2 (pt) 2015-12-15

Family

ID=41510762

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919857A BRPI0919857A2 (pt) 2008-10-21 2009-10-21 tratamentos para cancer com radiacao e imunocitocinas

Country Status (12)

Country Link
US (1) US20100330029A1 (enExample)
EP (1) EP2337579A1 (enExample)
JP (1) JP2012506394A (enExample)
KR (1) KR20110086101A (enExample)
CN (1) CN102196815A (enExample)
AU (1) AU2009306711A1 (enExample)
BR (1) BRPI0919857A2 (enExample)
CA (1) CA2741130A1 (enExample)
EA (1) EA201100626A1 (enExample)
MX (1) MX2011004193A (enExample)
WO (1) WO2010046097A1 (enExample)
ZA (1) ZA201103726B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3107573T (pt) * 2014-02-19 2019-01-10 Merck Patent Gmbh Imunoterapia com il-12 visada ao cancro
JP7165717B2 (ja) 2017-03-15 2022-11-04 パンディオン・オペレーションズ・インコーポレイテッド 標的免疫寛容
US9861833B1 (en) * 2017-03-30 2018-01-09 Norman H. Anderson Methods of treating melanoma
MX2019013517A (es) 2017-05-24 2020-08-17 Pandion Operations Inc Inmunotolerancia dirigida.
US10174091B1 (en) 2017-12-06 2019-01-08 Pandion Therapeutics, Inc. IL-2 muteins
USRE50550E1 (en) 2017-12-06 2025-08-26 Pandion Operations, Inc. IL-2 muteins and uses thereof
US10946068B2 (en) 2017-12-06 2021-03-16 Pandion Operations, Inc. IL-2 muteins and uses thereof
EP3972992A4 (en) 2019-05-20 2023-07-19 Pandion Operations, Inc. MADCAM TARGETED IMMUNOTLERANCE
WO2021168079A1 (en) 2020-02-21 2021-08-26 Pandion Operations, Inc. Tissue targeted immunotolerance with a cd39 effector
CN112768029B (zh) * 2020-12-27 2023-10-13 上海市东方医院（同济大学附属东方医院） 一种基于单细胞测序的组合用药推荐设备、方法及介质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2457701A (en) * 1999-12-28 2001-07-09 Brown University Research Foundation Methods and products for tumor immunotherapy using cytokines
ATE368475T1 (de) * 2000-06-29 2007-08-15 Emd Lexigen Res Ct Corp Steigerung von durch antikörper-zytokin- fusionsproteine mediierten immunantworten durch eine kombinierte behandlung mit mitteln zur erhöhung der immunzytokinaufnahme
PT1454138E (pt) * 2001-12-04 2012-03-28 Merck Patent Gmbh Imunocitoquinas com seletividade modulada
RU2007130552A (ru) * 2005-01-10 2009-02-20 Рисерч Дивелопмент Фаундейшн (US) Рекомбинантные молекулы направленного действия для лечения рака
PT1966238E (pt) * 2005-12-30 2012-07-31 Merck Patent Gmbh Uso de hsp70 como um regulador de atividade enzimática

Also Published As

Publication number Publication date
EA201100626A1 (ru) 2011-12-30
AU2009306711A1 (en) 2010-04-29
WO2010046097A1 (en) 2010-04-29
ZA201103726B (en) 2012-01-25
JP2012506394A (ja) 2012-03-15
KR20110086101A (ko) 2011-07-27
MX2011004193A (es) 2011-05-24
CN102196815A (zh) 2011-09-21
US20100330029A1 (en) 2010-12-30
CA2741130A1 (en) 2010-04-29
EP2337579A1 (en) 2011-06-29

Similar Documents

Publication Publication Date Title
BRPI0919857A2 (pt) tratamentos para cancer com radiacao e imunocitocinas
DE602009000539D1 (de) Strahlentherapiegerät
BRPI0908003A2 (pt) sistemas e métodos para o envio de terapia de radiação
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
BRPI0919238A2 (pt) métodos e composições para o tratamento de câncer
DE602008000456D1 (de) Strahlentherapievorrichtung
BRPI0818320A2 (pt) composição para tratamento de câncer de próstata (pca)
BRPI1007972A2 (pt) composições de combinação e métodos para o tratamento de câncer
DE602009001154D1 (de) Strahlentherapievorrichtung und Bestrahlungsverfahren
BR112012011570A2 (pt) aparelho para tratamento de fluido com radiação de microondas
BR112013014316A2 (pt) tratamento de câncer her2-positivo com paclitaxel e trastuzumabe-mcc-dm1
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
BRPI1008566A8 (pt) métodos e composições para o diagnóstico e tratamento de câncer
EP2422846A4 (en) CORPUSCULAR RADIATION THERAPY APPARATUS
DK2361116T3 (da) Bestrålingsindretning
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
BRPI1006438A2 (pt) terapia adjuvante de cancer
BRPI1010874A2 (pt) composição para o tratamento de câncer de próstata
BRPI1008564A2 (pt) métodos e composições para o dignóstico e tratamento de câncer
DK2219683T3 (da) Målrettet radioterapi
SMT201700056B (it) Fosfaplatine e relativo utilizzo per il trattamento di cancro
PT2632452T (pt) Compostos e composições para o tratamento do cancro
BRPI0922884A2 (pt) compostos para tratamento de câncer
BRPI0906444A2 (pt) Compostos de 4-piridinona e seu uso para câncer
GB0812753D0 (en) Electromagnetic radiation and its therapeutic effect

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.